Compagnie Financiere Richemont SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6947
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:小売り
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Compagnie Financiere Richemont SA – Strategy, SWOT and Corporate Finance Report
Summary

Compagnie Financiere Richemont SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Compagnie Financiere Richemont SA (Richemont or ‘the group’) is a luxury goods company specializing in jewelry, luxury watches and premium accessories. The company offers products such as jewelry, watches, leather goods, writing instruments, apparel, luxury watches, clothing and accessories. The company markets these products under various brands such as IWC Schaffhausen, Jaeger-LeCoultre, Alfred Dunhill, Lancel, Chloe, Azzedine Alaia, Purdey, Peter Millar, Cartier, Piaget, Van Cleef & Arpels, A. Lange & Sohne, Baume & Mercier, Roger Dubuis, Vacheron Constantin, Giampiero Bodino, Officine Panerai and Montblanc. The company’s operations are spread across Europe, Asia, Middle East, Africa and the US. Richemont is headquartered in Bellevue, Geneva, Switzerland.

Scope

- Detailed information on Compagnie Financiere Richemont SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Compagnie Financiere Richemont SA in the form of a SWOT analysis
- An in-depth view of the business model of Compagnie Financiere Richemont SA including a breakdown and examination of key business segments
- Intelligence on Compagnie Financiere Richemont SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Compagnie Financiere Richemont SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Compagnie Financiere Richemont SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Compagnie Financiere Richemont SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Compagnie Financiere Richemont SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Compagnie Financiere Richemont SA: Company Overview 9
Compagnie Financiere Richemont SA: Overview and Key Facts 9
Compagnie Financiere Richemont SA: Overview 9
Compagnie Financiere Richemont SA: Key Facts 9
Compagnie Financiere Richemont SA: Key Employees 11
Compagnie Financiere Richemont SA: Key Employee Biographies 13
Compagnie Financiere Richemont SA: Major Products and Services 17
Compagnie Financiere Richemont SA: Company History 18
Compagnie Financiere Richemont SA: Management Statement 21
Compagnie Financiere Richemont SA: Locations and Subsidiaries 24
Compagnie Financiere Richemont SA: Key Competitors 25
Compagnie Financiere Richemont SA: Company Analysis 26
Compagnie Financiere Richemont SA: Business Description 26
Compagnie Financiere Richemont SA: SWOT Analysis 27
Compagnie Financiere Richemont SA: SWOT Overview 27
Compagnie Financiere Richemont SA: Strengths 27
Compagnie Financiere Richemont SA: Weaknesses 28
Compagnie Financiere Richemont SA: Opportunities 28
Compagnie Financiere Richemont SA: Threats 29
Compagnie Financiere Richemont SA: Corporate Financial Deals Activity 30
Compagnie Financiere Richemont SA: Financial Deals Overview 30
Compagnie Financiere Richemont SA: Targets and Partners 32
Compagnie Financiere Richemont SA: Top Deals 2014 – 2018YTD* 33
Compagnie Financiere Richemont SA: Advisors 34
Compagnie Financiere Richemont SA: Top Legal Advisors 34
Compagnie Financiere Richemont SA: Mergers and Acquisitions 35
Compagnie Financiere Richemont SA: Capital Raising 36
Compagnie Financiere Richemont SA: Divestments 37
Compagnie Financiere Richemont SA: Recent Developments 38
Compagnie Financiere Richemont SA: News and Events Summary 38
Compagnie Financiere Richemont SA: Business Expansion 41
Compagnie Financiere Richemont SA: Contracts 41
Compagnie Financiere Richemont SA: Corporate Governance 42
Compagnie Financiere Richemont SA: Financial Performance 43
Compagnie Financiere Richemont SA: Market Developments 43
Compagnie Financiere Richemont SA: Red Flags/DistressSignals 44
Compagnie Financiere Richemont SA: Regulatory and Legal Events 44
Compagnie Financiere Richemont SA: Strategy and Operations 44
Appendix 45
Contact Us 45
Methodology 45
About MarketLine 46

List of Tables
Table 1: Compagnie Financiere Richemont SA: Key Facts
Table 2: Compagnie Financiere Richemont SA: Key Employees
Table 3: Compagnie Financiere Richemont SA: Company History
Table 4: Compagnie Financiere Richemont SA: Locations and Subsidiaries
Table 5: Compagnie Financiere Richemont SA: Key Competitors
Table 6: Compagnie Financiere Richemont SA: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Compagnie Financiere Richemont SA: M&A Activity by Geography (TTM*)
Table 8: Compagnie Financiere Richemont SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Compagnie Financiere Richemont SA: M&A Average Deal Size - Value (US$m)
Table 10: Compagnie Financiere Richemont SA: Targets and Partners
Table 11: Compagnie Financiere Richemont SA: Top Deals 2014 - 2018YTD*
Table 12: Compagnie Financiere Richemont SA: Legal Advisor Ranking by Value (US$m)
Table 13: Compagnie Financiere Richemont SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Compagnie Financiere Richemont SA: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Compagnie Financiere Richemont SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 16: Compagnie Financiere Richemont SA: Capital Raising by Deal Type (2014 - YTD*2018)
Table 17: Compagnie Financiere Richemont SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 18: Compagnie Financiere Richemont SA: Divestments by Geography (2014 - YTD*2018)
Table 19: Compagnie Financiere Richemont SA: News and Events Summary
Table 20: Compagnie Financiere Richemont SA: Business Expansion
Table 21: Compagnie Financiere Richemont SA: Contracts
Table 22: Compagnie Financiere Richemont SA: Corporate Governance
Table 23: Compagnie Financiere Richemont SA: Financial Performance
Table 24: Compagnie Financiere Richemont SA: Market Developments
Table 25: Compagnie Financiere Richemont SA: Red Flags/DistressSignals
Table 26: Compagnie Financiere Richemont SA: Regulatory and Legal Events
Table 27: Compagnie Financiere Richemont SA: Strategy and Operations

List of Figures
Figure 1: Compagnie Financiere Richemont SA: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Compagnie Financiere Richemont SA: M&A Activity by Geography (TTM*)
Figure 3: Compagnie Financiere Richemont SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Compagnie Financiere Richemont SA: M&A Average Deal Size - Value (US$m)
Figure 5: Compagnie Financiere Richemont SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Compagnie Financiere Richemont SA: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Compagnie Financiere Richemont SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: Compagnie Financiere Richemont SA: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 9: Compagnie Financiere Richemont SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Compagnie Financiere Richemont SA: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Compagnie Financiere Richemont SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Caixa Economica Federal:企業の戦略・SWOT・財務分析
    Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report Summary Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Goldin Financial Holdings Ltd:企業の戦略・SWOT・財務情報
    Goldin Financial Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Goldin Financial Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Gordon Food Service:戦略・SWOT・企業財務分析
    Gordon Food Service - Strategy, SWOT and Corporate Finance Report Summary Gordon Food Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Crystal Pharmatech Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Crystal Pharmatech Co Ltd (Crystal Pharmatech) is a contract research organization that conducts research on engineering and materials science for drug development. The organization offers pharmaceutical solid-state research services such as solid form screening and selection, single crystal …
  • Svelte Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Svelte Medical Systems Inc (Svelte) is a medical device company that manufactures and designs balloon expandable stents. The company offers products such as balloon expandable stents, svelte acrobat, and drug eluting stents, among others. Its svelte acrobat is a stent-on-a-wire bare metal co …
  • Checkpoint Therapeutics Inc (CKPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Checkpoint Therapeutics Inc (Checkpoint Therapeutics), a subsidiary of Fortress Biotech Inc, is a clinical-stage biopharmaceutical company that acquires, develops and commercializes non-chemotherapy and immune enhanced combination treatments for the treatment of solid tumor cancers. The comp …
  • Dongbu Corporation:企業の戦略・SWOT・財務情報
    Dongbu Corporation - Strategy, SWOT and Corporate Finance Report Summary Dongbu Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CIMIC Group Ltd (CIM):企業の財務・戦略的SWOT分析
    CIMIC Group Ltd (CIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CJ HealthCare Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary CJ HealthCare Corp (CJ HealthCare), a subsidiary CJ CheilJedang Corp, is a provider of active pharmaceutical ingredients, OTC drugs and pharmaceutical medicines. The company’s portfolio includes biologicals, antibiotics, anti cancer, parenteral nutrition, total parenteral nutrition products. …
  • Karyopharm Therapeutics Inc (KPTI):企業の財務・戦略的SWOT分析
    Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Premier Oil plc:企業の戦略・SWOT・財務分析
    Premier Oil plc - Strategy, SWOT and Corporate Finance Report Summary Premier Oil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Islandsbanki hf.:企業の戦略・SWOT・財務分析
    Islandsbanki hf. - Strategy, SWOT and Corporate Finance Report Summary Islandsbanki hf. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cohera Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cohera Medical Inc (Cohera) is a medical device company that designs and develops surgical adhesives and sealants. The company provides products such as TissuGlu surgical adhesive, Sylys surgical sealant, and others. Its TissuGlu surgical adhesive is biocompatible for internal use, and forms …
  • SynergEyes Inc-医療機器分野:企業M&A・提携分析
    Summary SynergEyes Inc (SynergEyes) is a medical device company that offers contact lenses. The company offers hybrid contact lenses to transform vision for patients with astigmatism, presbyopia, presbyopia, myopia, hyperopia, keratoconus, and other eye conditions. It provides ultrahealth hybrid len …
  • Copenhagen Airports AS:企業の戦略・SWOT・財務情報
    Copenhagen Airports AS - Strategy, SWOT and Corporate Finance Report Summary Copenhagen Airports AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Machavert Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Machavert Pharmaceuticals LLC (Machavert Pharmaceuticals) is a bio-pharmaceutical company which develops novel non-toxic medicines for the treatment of cancer and autoimmune diseases. Its lead drug candidate MP1000, a nanoparticulate liposomal phospholipid immune-modulating agent exhibits an …
  • VWR International LLC-医療機器分野:企業M&A・提携分析
    Summary VWR International LLC (VWR), a subsidiary of VWR Corp is a medical device company that offers healthcare equipment. The company’s products comprise adhesive dispensers, adhesive labels, adhesive slides, agarose and acrylamide, air freshener dispensers, air regulation valves, aluminum foil, a …
  • Sarepta Therapeutics Inc (SRPT):企業の財務・戦略的SWOT分析
    Sarepta Therapeutics Inc (SRPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Renco Group SpA:企業の戦略的SWOT分析
    Renco Group SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆